Custom Services International.
This article was originally published in The Gray Sheet
Petitions FDA to revise its Sept. 30 final rule on natural rubber latex containing devices. The firm requests that the agency eliminate the requirement that condom manufacturers must print the statement: "Caution: This Product Contains Natural Rubber Latex Which May Cause Allergic Reactions" on individually wrapped condoms. Echoing concerns initially expressed by the Health Industry Manufacturers Association in October 1996, the petition notes that the additional statement "cannot be placed on the principal display panel...without regulatory relief as to some other required statement, or a waiver for further decrease in the type size" ("The Gray Sheet" Oct. 6, p. 3). The firm believes the existing warnings printed on the packaging are sufficient...
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.